Actavis Launches Latin America Business Unit

BMI View: Switzerland-based Actavis has deflected disappointing news in Poland by announcing an aggressive growth strategy in Latin America. Despite being a late entrant into the region's growing pharmaceuticals market, we anticipate the strategy to target Brazil and Colombia, bearing fruit for the generic drugmaker.

To read the full article, please choose one of the following options: